Adderall and Mavyret drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adderall (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) and Mavyret (glecaprevir; pibrentasvir). Common drug interactions include nausea among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Adderall and Mavyret. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Adderall?

Adderall has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 64,224 Adderall users. Check the latest studies of Adderall.

What is Mavyret?

Mavyret has active ingredients of glecaprevir; pibrentasvir. eHealthMe is studying from 10,533 Mavyret users. Check the latest studies of Mavyret.



On Jul, 20, 2026

32 people who take Adderall and Mavyret together, and have interactions are studied.

Adderall and Mavyret drug interactions.

What are the common drug interactions of Adderall and Mavyret, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Dysgeusia (disorder of the sense of taste)
  3. Fatigue (feeling of tiredness)
  4. Vomiting
  5. Anaphylactic reaction (serious allergic reaction)
  6. Diarrhoea
  7. Headache (pain in head)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  10. Rash

male:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Decreased appetite
  4. Gastric ph decreased
  5. White blood cell count increased
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Pancreatic carcinoma stage ii (pancreatic cancer stage ii)
  8. Suicide attempt
  9. Dandruff
  10. Skin infection

What are the common drug interactions of Adderall and Mavyret, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diarrhoea
  2. Gastrointestinal pain
  3. General physical health deterioration (weak health status)
  4. Hallucination (an experience involving the perception of something not present)
  5. Hepatic pain (pain in liver)
  6. Visual impairment
  7. Weight decreased
  8. Decreased appetite
  9. Fatigue (feeling of tiredness)
  10. Gastric ph decreased

30-39:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Dysgeusia (disorder of the sense of taste)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  5. Diarrhoea
  6. Headache (pain in head)
  7. Nausea (feeling of having an urge to vomit)
  8. Pancreatic carcinoma stage ii (pancreatic cancer stage ii)
  9. Suicide attempt
  10. Agitation (state of anxiety or nervous excitement)

40-49:

  1. Gastric disorder (disease of stomach)
  2. Influenza
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Rash
  5. Skin infection
  6. Therapeutic response unexpected
  7. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

  1. Diarrhoea
  2. Hepatitis c
  3. Nail disorder (disease of nail)
  4. Nausea (feeling of having an urge to vomit)
  5. Rash
  6. Vomiting
  7. Colitis (inflammation of colon)

60+:

  1. Balance disorder
  2. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  3. Dysarthria (speech disorder)
  4. Fatigue (feeling of tiredness)
  5. Nausea (feeling of having an urge to vomit)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Visual impairment
  9. Vomiting

What are the existing conditions these people have? *

  1. Hepatitis C: 8 people, 25.00%
  2. Stress And Anxiety: 3 people, 9.38%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.38%
  4. Disturbance In Attention: 3 people, 9.38%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 6.25%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 6.25%
  7. Hypersensitivity: 2 people, 6.25%
  8. Depression: 2 people, 6.25%
  9. Birth Control: 2 people, 6.25%
  10. Asthma: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Adderall and Mavyret?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Adderall and Mavyret:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adderall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mavyret:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adderall and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mavyret and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate and glecaprevir; pibrentasvir (the active ingredients of Adderall and Mavyret, respectively), and Adderall and Mavyret (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: